Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2017

Open Access 01-12-2017 | Research article

Association between self-perception of aging, view of cancer and health of older patients in oncology: a one-year longitudinal study

Authors: Sarah Schroyen, Pierre Missotten, Guy Jerusalem, M. Van den Akker, F. Buntinx, Stéphane Adam

Published in: BMC Cancer | Issue 1/2017

Login to get access

Abstract

Background

Identifying older people affected by cancer who are more at risk of negative health outcomes is a major issue in health initiatives focusing on medical effectiveness. In this regard, psychological risk factors such as patients’ perception of their own aging and cancer could be used as indicators to improve customization of cancer care. We hypothesize that more negative self-perception of aging (SPA) and view of cancer could be linked to worse physical and mental health outcomes in cancer patients.

Methods

One hundred one patients diagnosed with cancer (breast, gynecological, lung or hematological) were followed for 1 year. They were evaluated on four occasions (baseline, 3, 6 and 12 months after the baseline). Their SPA, view of cancer and health (physical and mental) were assessed at each time of evaluation.

Results

Negative SPA and/or view of cancer at baseline are associated with negative evolution of patients’ physical and mental health. Moreover, when the evolution of SPA and cancer view were taken into account, these two stigmas are still linked with the evolution of mental health. In comparison, only a negative evolution of SPA was linked to worse physical health outcomes.

Conclusions

Such results indicate that SPA and view of cancer could be used as markers of vulnerability in older people with cancer.
Appendix
Available only for authorised users
Literature
1.
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403.CrossRefPubMed
2.
Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009;27:2758–65.CrossRefPubMed
3.
4.
Hurria A, Browner IS, Cohen HJ, Denlinger CS. deShazo M, Extermann M, Ganti AK, Holland JC, Holmes HM, Karlekar MB et al. senior adult oncology. J Natl Compr Cancer Netw. 2012;10:162–209.CrossRef
5.
Extermann M, Overcash J, Lyman GH, Parr J, Balducci L. Comorbidity and functional status are independent in lder cancer patients. J Clin Oncol. 1998;16:1582–7.CrossRefPubMed
6.
Janssen I, Mark AE. Elevated body mass index and mortality risk in the elderly. Obes Rev. 2007;8:41–59.CrossRefPubMed
7.
Newman A, Yanez D, Harris T, Duxbury A, Enright P, Fried L. Weight change in old age and its association with mortality. J Am Geriatr Soc. 2001;49:1309–18.CrossRefPubMed
8.
Manzoli L, Villari P. G MP, Boccia a. Marital status and mortality in the elderly: a systematic review and meta-analysis. Soc Sci Med. 2007;64:77–94.CrossRefPubMed
9.
Xie J, Brayne C, Matthews FE. Medical Research Council cognitive F, ageing study c. Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up. BMJ. 2008;336:258–62.CrossRefPubMedPubMedCentral
10.
Levy B. Mind matters: cognitive and physical effects of aging self-stereotypes. J Gerontol B Psychol Sci Soc Sci. 2003;58:203–11.CrossRef
11.
12.
Levy B, Slade MD, Kasl SV. Longitudinal benefit of positive self-perceptions of aging on functional health. J Gerontol B Psychol Sci Soc Sci. 2002;57:409–17.CrossRef
13.
Levy B, Zonderman AB, Slade MD, Ferrucci L. Age stereotypes held earlier in life predict cardiovascular events in later life. Psychol Sci. 2009;20:296–8.CrossRefPubMedPubMedCentral
14.
Levy B, Slade MD, Kunkel SR, Kasl SV. Longevity increased by positive self-perceptions of aging. J Pers Soc Psychol. 2002;83:261–70.CrossRefPubMed
15.
Levy B, Myers LM. Preventive health behaviors influenced by self-perceptions of aging. Prev Med. 2004;39(3):625–9.CrossRefPubMed
16.
Levy B, Ashman O, Dror I. To be or not to be the effects of aging stereotypes on the will to live. Omega. 2000;40:409–20.
17.
Marques S, Lima ML, Abrams D, Swift H. Will to live in older people's medical decisions: immediate and delayed effects of aging stereotypes. J Appl Soc Psychol. 2014;44:399–408.CrossRef
18.
Fujisawa D, Hagiwara N. Cancer stigma and its health consequences. Curr Breast Cancer Rep. 2015;7:143–50.CrossRef
19.
Clarke JN, Everest MM. Cancer in the mass print media: fear, uncertainty and the medical model. Soc Sci Med. 2006;62:2591–600.CrossRefPubMed
20.
Cataldo JK, Jahan TM, Pongquan VL. Lung cancer stigma, depression, and quality of life among ever and never smokers. Eur J Oncol Nurs. 2011;16:264–9.CrossRefPubMedPubMedCentral
21.
Cho J, Choi EK, Kim SY, Shin DW, Cho BL, Kim CH, Koh DH, Guallar E, Bardwell WA, Park JH. Association between cancer stigma and depression among cancer survivors: a nationwide survey in Korea. Psychooncology. 2013;22:2372–8.CrossRefPubMed
22.
Schroyen S, Marquet M, Jerusalem G, Dardenne B, Van den Akker M, Buntinx F, Adam S, Missotten P. The link between self-perceptions of aging, cancer view and physical and mental health of older people with cance. J Geriatr Oncol. In press
23.
Kalafat M, Hugonot-Diener L, Poitrenaud J. Standardisation et étalonnage français du "Mini Mental State" (MMS) version GRECO. Rev Neuropsychol. 2003;13:209–36.
24.
Laidlaw K, Power MJ, Schmidt S, Group W-O. The attitudes to ageing questionnaire (AAQ): development and psychometric properties. Int J Geriatr Psychiatry. 2007;22:367–79.CrossRefPubMed
25.
Marquet M, Missotten P, Schroyen S, Van Sambeek I, Van Den Broeke C, Buntinx F, Adam S. A French validation of the attitudes to ageing questionnaire (AAQ): factor structure, Reliability and Validity. Psychol Belg. 2016;56:1–21.
26.
Fife BL, Wright ER. The dimensionality of stigma: a comparison of its impact on the self of persons with HIV-AIDS and cancer. J Health Soc Behav. 2000;41:50–67.CrossRefPubMed
27.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, De Haes JC, et al. The European Organization for Research and Treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.CrossRefPubMed
28.
Giesinger JM, Kieffer JM, Fayers PM, Groenvold M, Petersen MA, Scott NW, Sprangers MA, Velikova G, Aaronson NK, Group EQoL. Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. J Clin Epidemiol. 2016;69:79–88.CrossRefPubMed
29.
30.
Glymour MM, Weuve J, Berkman LF, Kawachi I, Robins JM. When is baseline adjustment useful in analyses of change? An example with education and cognitive change. Am J Epidemiol. 2005;162:267–78.CrossRefPubMed
31.
Levy B, Hausdorff JM, Hencke R, Wei JY. Reducing cardiovascular stress with positive self-stereotypes of aging. J Gerontol B Psychol Sci Soc Sci. 2000;55:205–13.CrossRef
32.
Yeom HE, Heidrich SM. Effect of perceived barriers to symptom management on quality of life in older breast cancer survivors. Cancer Nurs. 2009;32:309–16.CrossRefPubMedPubMedCentral
33.
Cataldo JK, Brodsky JL. Lung cancer stigma, anxiety, depression and symptom severity. Oncology. 2013;85:33–40.CrossRefPubMed
34.
Robb C, Boulware D, Overcash J, Extermann M. Patterns of care and survival in cancer patients with cognitive impairment. Crit Rev Oncol Hematol. 2010;74:218–24.CrossRefPubMed
35.
Klepin HD, Geiger AM, Tooze JA, Kritchevsky SB, Williamson JD, Pardee TS, Ellis LR, Powell BL. Geriatric assessment predicts survival for older adults receiving chemotherapy for acute myelogenous leukemia. Am Soc Hematol. 2013;121:4287–94.
36.
Dubruille S, Libert Y, Roos M, Vandenbossche S, Collard A, Meuleman N, Maerevoet M, Etienne AM, Reynaert C, Razavi D, et al. Identification of clinical parameters predictive of one-year survival using two geriatric tools in clinically fit older patients with hematological malignancies: major impact of cognition. J Geriatr Oncol. 2015;6:362–9.CrossRefPubMed
37.
Schroyen S, Adam S, Jerusalem G, Missotten P. Ageism and its clinical impact in oncogeriatry: state of knowledge and therapeutic leads. Clin Interv Aging. 2015;10:117–25.PubMed
38.
Harrison T, Blozis S, Stuifbergen A. Longitudinal predictors of attitudes toward aging among women with multiple sclerosis. Psychol Aging. 2008;23:823–32.CrossRefPubMedPubMedCentral
39.
Levy B, Pilver C, Chung PH, Slade MD. Subliminal strengthening: improving older individuals' physical function over time with an implicit-age-stereotype intervention. Psychol Sci. 2014;25:2127–35.CrossRefPubMedPubMedCentral
40.
Stewart TL, Chipperfield JG, Perry RP, Weiner B. Attributing illness to “old age”: consequences of a self-directed stereotype for health and mortality. Psychol Health. 2012;27:881–97.CrossRefPubMed
Metadata
Title
Association between self-perception of aging, view of cancer and health of older patients in oncology: a one-year longitudinal study
Authors
Sarah Schroyen
Pierre Missotten
Guy Jerusalem
M. Van den Akker
F. Buntinx
Stéphane Adam
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2017
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-017-3607-8

Other articles of this Issue 1/2017

BMC Cancer 1/2017 Go to the issue

Research article

Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding

Research article

Adipose tissue fibrosis in human cancer cachexia: the role of TGFβ pathway

Research article

Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma

Research article

Characteristics of early-onset hematotoxicity of sunitinib in Japanese patients with renal cell carcinoma

Research article

MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer

Research article

Stress alters the expression of cancer-related genes in the prostate
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits